This a simple analysis which is probably worth doing, though not for the reasons given. By the time the participants have metastatic cancer and have received other forms of androgen deprivation therapy, chemotherapy or corticosteroids, their BMI may have changed greatly from the time of onset of their cancer, so the mechanistic justification for the analysis does not hold. It is unlikely that the data set will contain any information about BMI at the time of initial diagnosis.